Responses
Oral Presentations
Axial spondyloarthritis and psoriatic arthritis: emerging pathways
OP0002 Tofacitinib in Patients with Ankylosing Spondylitis: A Phase 2, 16-Week, Randomised, Placebo-Controlled, Dose-Ranging Study
Compose a Response to This Article
Other responses
No responses have been published for this article.